Development and Maintenance of Post-Acute Care Cross-Setting Standardized Assessment Data (Second Public Comment) - Comment period opens on April 26, 2017 and closes on June 26, 2017.
The Centers for Medicare & Medicaid Services (CMS) has contracted with the RAND Corporation to develop standardized patient/resident assessment data elements in alignment with the Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act).
CMS seeks comments from stakeholders on data elements that meet the IMPACT Act domains of cognitive function and mental status; medical conditions and co-morbidities; impairments; medication reconciliation; and care preferences.
Project Overview: The Centers for Medicare & Medicaid Services (CMS) has contracted with RAND to develop standardized assessment-based data items to meet the requirements as set forth under the IMPACT Act of 2014, Section 2(a). The contract name is “Development and Maintenance of Post-Acute Care Cross-Setting Standardized Assessment Data”. The contract number is HHSM-500-2013-13014I. As part of its data element development process, CMS requests interested parties to submit comments on the data elements described in this posting, which are being considered for this project
Project Objectives: To develop standardized assessment-based data elements to meet the requirements as set forth under the IMPACT Act of 2014, Section 2(a). Development of standardized data elements includes conducting environmental scans of the evidence, data element conceptualization, drafting data element specifications, convening technical expert panels, and feasibility piloting.
Documents and Measures for Comment:
The following document are provided for your review and comment.
Project Specific Instructions: The Centers for Medicare & Medicaid Services (CMS) seeks comments from stakeholders on data elements that meet the IMPACT Act domains of: cognitive function and mental status; medical conditions and co-morbidities; impairments; medication reconciliation; and care preferences. In this document, we summarize each data element including background and element use.
In addition to general comments, CMS is specifically interested in public feedback regarding the topics below. Please consider these topics during your review of the draft data item specifications:
- Potential for improving quality, which includes consideration of the data element’s ability to improve care transitions through meaningful exchange of data between providers; improve person-centered care and care planning; be used for quality comparisons; and support clinical decision-making and care coordination;
- Validity, which includes consideration of the data element’s proven or likely inter-rater reliability (i.e., consensus in ratings by two or more assessors) and validity (i.e., whether it captures the patient attribute being assessed);
- Feasibility for use in PAC, which includes consideration of the data element’s potential to be standardized and made interoperable across settings; clinical appropriateness; and relevance to the work flow across settings;
- Utility for describing case mix, which includes whether the data element could be used with different payment models, and whether it measures differences in patient severity levels related to resource needs.
Do not include personal health information in your comments. If you are providing comments on behalf of an organization, include the organization’s name and your contact information.
If you are commenting as an individual, submit identifying or contact information. You may submit general comments on the entire set of data elements or you may provide comments specific to individual data elements. Send your comments to impactpubliccomment@rand.org or to: RAND Corporation, 20 Park Plaza, 9th Floor, Suite 920, Boston, MA 02116. Attn: Noreen Khan, Mailstop: BN-1
Comments are due by June 26, 2017 by 11:59pm- For more information, view the public comment webpage.